Registration for JAX Scientific Sessions

Join us July 13th and July 27th as we take a look at what our world-class researchers are doing in immuno-oncology, tumor biology, and experimental and molecular therapeutics.

Scientific Oncology Session Agendas

July 13 Agenda - 12:30 – 2:35 EDT

  • Danying Cai, Ph.D. - A Rapid, Sensitive, and Reproducible PBMC-Humanized Mouse Model for Quantitating Cytokine Release Syndrome Caused by Immunotherapy
  • Hongyuan Yang, M.D. - Dose Response and Time Course of TGN1412 Induced Human Cytokines in a Humanized PBMC Mouse Model for Cytokine Release Syndrome
  • Jing Jiao, Ph.D. - Preclinical Evaluation of Potential Cytokine Release Syndrome and Efficacy of Bispecific Antibodies in PBMC-Humanized Mice
  • Jing Jiao, Ph.D. - Preclinical Mouse Model to Evaluate Efficacy and Potential Cytokine Release Syndrome of Chimeric Antigen Receptor (CAR) T Cell Therapy
  • Jiwon Yang, Ph.D. - Effect of Aging on Toxicity, Efficacy, and Immunomodulation via Chemotherapy in C57BL/6J Syngeneic Model

July 27 Agenda - 12:30 – 2:20 EDT

  • Kyle Draheim, Ph.D. - Evaluating the Growth Kinetics, Histology, and Drug Response in PDX Breast Cancer Models Implanted Subcutaneously Versus in the Mammary Fat Pad
  • Presented by: Brian Soper, Ph.D. - (By: Li-Chin Yao, Ph.D.): Humanized Mouse Model for Evaluation of Bispecific Antibody Efficacy and Drug-Induced Cytokine Release
  • Presented by: Brian Soper, Ph.D. - (By: Li-Chin Yao, Ph.D.): Humanized NSG-Tg(Hu-IL15) Mouse Model for Evaluation of NK cells Based Drug Efficacy
  • Presented by: Brian Soper, Ph.D. - (By: Li-Chin Yao, Ph.D.): PBMC-Humanized NSG-(KbDb)null (IA)null Mouse Model for Evaluation of Immuno-Oncology Drug Efficacy